To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene OSBPL8TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
546 supporting clones for gene OSBPL8 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA504454 brain .a 1 to 572 8 to 579   tiling clone, capped   578/579
(99 %)
2 diff
(99.7 %id)
DA472389   .a 26 to 554 2 to 530   capped   529/529
(100 %)
1 diff
(99.9 %id)
AU310076 neuroblastoma .a 26 to 431 1 to 406   fully sequenced,   406/406
(100 %)
1 diff
(99.8 %id)
DB093591 testis .a 27 to 581 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BI226706 Burkitt lymphoma, lymph .a 48 to 686 1 to 650       650/675
(96 %)
16 diff
(97.7 %id)
BC082235 Lymph, Burkitt lymphoma .a 49 to 2627 1 to 2579   available from MGC, AAA   2579/2579
(100 %)
0 diff
(100 %id)
DA338210 hippocampus .a 56 to 642 2 to 588   capped   587/587
(100 %)
2 diff
(99.7 %id)
BE513563 Burkitt lymphoma, lymph .a 68 to 753 1 to 683       683/698
(97 %)
6 diff
(99.2 %id)
BE513372 Burkitt lymphoma, lymph .a 69 to 633 1 to 567   available from MGC,   567/567
(100 %)
2 diff
(99.7 %id)
BC111728 PCR rescued clones .a 94 to 4537 1 to 4444 exact tiling clone,   4444/4444
(100 %)
0 diff
(100 %id)
AA282204 germinal center B cell .a 228 to 576 1 to 349     Submitted on the opposite strand 349/349
(100 %)
3 diff
(99.2 %id)
AI573242 anaplastic oligodendroglioma, brain .a 228 to 735 1 to 508     Submitted on the opposite strand 508/508
(100 %)
0 diff
(100 %id)
BF512440   .a 229 to 621 1 to 393     Submitted on the opposite strand 393/393
(100 %)
0 diff
(100 %id)
AI274052 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 247 to 654 1 to 408     Submitted on the opposite strand 408/408
(100 %)
0 diff
(100 %id)
AI057033 B-cell, chronic lymphotic leukemia .a 255 to 670 1 to 416     Submitted on the opposite strand 416/416
(100 %)
4 diff
(99.1 %id)
AI627266 Kidney .a 263 to 721 1 to 459     Submitted on the opposite strand 459/459
(100 %)
2 diff
(99.6 %id)
AI885288 anaplastic oligodendroglioma, brain .a 263 to 735 1 to 473     Submitted on the opposite strand 473/473
(100 %)
3 diff
(99.4 %id)
AW665098 pooled .a 264 to 681 1 to 418     Submitted on the opposite strand 418/418
(100 %)
0 diff
(100 %id)
AK289997 hippocampus .a 268 to 3185 1 to 2918 exact     2918/2918
(100 %)
1 diff
(100.0 %id)
DA325766 hippocampus .a 269 to 819 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
AW340280 pooled .a 278 to 641 1 to 364     Submitted on the opposite strand 364/364
(100 %)
1 diff
(99.8 %id)
AA806920 germinal center B cell .a 293 to 663 1 to 369     Submitted on the opposite strand 369/369
(100 %)
4 diff
(99.0 %id)
AA808301 germinal center B cell .a 304 to 714 1 to 410     Submitted on the opposite strand 410/410
(100 %)
1 diff
(99.8 %id)
AB040884 brain .a 317 to 7226 1 to 6909 exact available from KIAA, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 6909/6909
(100 %)
1 diff
(100.0 %id)
AU310077 neuroblastoma .a 370 to 852 483 to 1   fully sequenced,   483/483
(100 %)
0 diff
(100 %id)
TI_891529974   .a 381 to 1519 46 to 1180     Submitted on the opposite strand 1135/1255
(90 %)
22 diff
(98.3 %id)
TI_891530320   .a 381 to 1139 786 to 29       758/1245
(60 %)
5 diff
(99.6 %id)
TI_891530321   .a 381 to 878 511 to 14       498/1231
(40 %)
5 diff
(99.6 %id)
TI_927047778   .a 381 to 1519 45 to 1174     Submitted on the opposite strand 1130/1291
(87 %)
21 diff
(98.4 %id)
T07315   .a 388 to 685 1 to 298       298/338
(88 %)
1 diff
(99.8 %id)
BC093834 Brain, cerebral cortex, PCR rescued clones .a 389 to 3197 1 to 2809 exact     2809/2809
(100 %)
0 diff
(100 %id)
BC101529 Brain, cerebral cortex, PCR rescued clones .a 389 to 3197 1 to 2809 exact     2809/2809
(100 %)
0 diff
(100 %id)
TI_927043088   .a 400 to 1579 68 to 1246     Submitted on the opposite strand 1178/1266
(93 %)
25 diff
(98.1 %id)
AF392452   .a 401 to 7226 415 to 7240 exact tiling clone,   7240/7240
(100 %)
1 diff
(100.0 %id)
TI_927047615   .a 401 to 1552 74 to 1240     Submitted on the opposite strand 1166/1300
(89 %)
34 diff
(97.4 %id)
NM_020841.4   .a 401 to 7226 414 to 7239 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 7239/7239
(100 %)
0 diff
(100 %id)
TI_927047706   .a 429 to 1569 6 to 1144       1139/1266
(89 %)
12 diff
(99.1 %id)
TI_891529811   .a 433 to 1635 8 to 1195       1188/1262
(94 %)
38 diff
(97.0 %id)
BX647211 amygdala .a 435 to 7217 1 to 6786 N184K G185N Q186G W187Q V188W ... available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 6786/6786
(100 %)
10 diff
(99.9 %id)
AA282320 germinal center B cell .a 448 to 835 396 to 9     Submitted on the opposite strand 388/396
(97 %)
0 diff
(100 %id)
TI_891530319   .a 509 to 1503 998 to 3       996/1209
(82 %)
1 diff
(100.0 %id)
DA626130 Kidney .b 1 to 541 2 to 543   tiling clone, capped   542/542
(100 %)
1 diff
(99.9 %id)
DB320641 Kidney .b 2361 to 2910 551 to 1   tiling clone,   551/551
(100 %)
3 diff
(99.5 %id)
CR749542 uterus endothel, primary cell culture .c 1 to 7044 1 to 7043 N142M G143V Q144S W145G V146* tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 7043/7043
(100 %)
8 diff
(99.9 %id)
AI702743 pooled .c 8 to 313 1 to 310     Submitted on the opposite strand 310/310
(100 %)
4 diff
(98.8 %id)
AA127802 uterus .c 255 to 573 331 to 12   tiling clone, Submitted on the opposite strand 320/441
(72 %)
1 diff
(99.8 %id)
AA031639 uterus .c 4814 to 5214 1 to 409       409/412
(99 %)
12 diff
(97.1 %id)
DA750018   .c 5727 to 6301 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
EC558517 Prostate .c 5738 to 5835 104 to 9       96/114
(84 %)
2 diff
(98.3 %id)
AA243888 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 5762 to 6127 1 to 366       366/366
(100 %)
0 diff
(100 %id)
EH351932   .c 5765 to 5848 1 to 84       84/84
(100 %)
0 diff
(100 %id)
FN124602 breast carcinoma .c 5774 to 5869 94 to 1     Submitted on the opposite strand 94/95
(98 %)
2 diff
(97.9 %id)
CN373529 embryonic stem cells, DMSO-treated H9 cellline .c 5789 to 6288 1 to 500       500/500
(100 %)
0 diff
(100 %id)
BG623925 placenta .c 5796 to 6617 1 to 816       816/817
(99 %)
25 diff
(97.0 %id)
BX281175 embryonal carcinoma, cell line, testis .c 5842 to 6340 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BQ421129 embryonal carcinoma, cell line, testis .c 5843 to 6677 1 to 836       836/836
(100 %)
2 diff
(99.8 %id)
BF727052 eye, lens .c 5901 to 6422 1 to 522       522/522
(100 %)
0 diff
(100 %id)
CK821123 Islets of Langerhans, Pancreas .c 5901 to 6499 1 to 599       599/599
(100 %)
0 diff
(100 %id)
BI793301 Islets of Langerhans, Pancreas .c 5917 to 6405 1 to 489       489/489
(100 %)
0 diff
(100 %id)
CN373533 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 5968 to 6638 1 to 671       671/671
(100 %)
1 diff
(99.9 %id)
CN373526 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 5980 to 6491 1 to 512       512/512
(100 %)
0 diff
(100 %id)
BE815161 breast_normal .c 6009 to 6543 7 to 541       535/549
(97 %)
6 diff
(99.0 %id)
BI086646 cervix .c 6042 to 6549 1 to 508       508/510
(99 %)
3 diff
(99.5 %id)
R37880 placenta .c 6043 to 6441 1 to 407       407/410
(99 %)
20 diff
(95.2 %id)
R68120 placenta .c 6043 to 6381 1 to 350       350/350
(100 %)
13 diff
(96.3 %id)
R66932 placenta .c 6043 to 6420 1 to 380       380/388
(97 %)
3 diff
(99.3 %id)
R72991 placenta .c 6043 to 6437 1 to 400       400/400
(100 %)
10 diff
(97.5 %id)
TI_149291599   .c 6105 to 7041 999 to 81   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 919/937
(98 %)
25 diff
(97.4 %id)
BX116965   .c 6116 to 6813 1 to 699       699/699
(100 %)
2 diff
(99.8 %id)
AA401862   .c 6116 to 6618 1 to 503       503/503
(100 %)
9 diff
(98.3 %id)
BE719628 head_neck .c 6145 to 6531 386 to 1       386/386
(100 %)
3 diff
(99.3 %id)
BE719659 head_neck .c 6145 to 6501 361 to 5       357/361
(98 %)
0 diff
(100 %id)
BU617202 Bone, Subchondral Bone .c 6145 to 6829 703 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 685/685
(100 %)
0 diff
(100 %id)
CD299087 Blood vessels - aorta, basilar and artery .c 6179 to 6804 1 to 629       629/776
(81 %)
15 diff
(98.1 %id)
EH316590   .c 6181 to 6248 1 to 67       67/67
(100 %)
1 diff
(98.6 %id)
CD102436 Pooled-Skin .c 6190 to 6774 1 to 599       599/795
(75 %)
22 diff
(97.3 %id)
TI_149287522   .c 6209 to 7041 904 to 80   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 825/1056
(78 %)
13 diff
(98.8 %id)
TI_149309670   .c 6209 to 7041 912 to 88   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 825/957
(86 %)
11 diff
(98.9 %id)
AW206528   .c 6254 to 6684 9 to 439     Submitted on the opposite strand 431/439
(98 %)
6 diff
(98.7 %id)
TI_153990602   .c 6254 to 6760 70 to 577     Submitted on the opposite strand 508/580
(87 %)
15 diff
(97.5 %id)
BM974206 lung .c 6268 to 7041 785 to 13   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 773/777
(99 %)
1 diff
(99.9 %id)
BU688048 lung .c 6268 to 7041 784 to 13   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 772/775
(99 %)
2 diff
(99.8 %id)
CN373530 embryonic stem cells, DMSO-treated H9 cellline .c 6279 to 6532 14 to 267       254/267
(95 %)
6 diff
(97.8 %id)
BP386469 pancreatic islet .c 6306 to 6655 1 to 353     Submitted on the opposite strand 353/357
(98 %)
6 diff
(98.4 %id)
BM972831 lung .c 6320 to 7041 734 to 13   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 722/722
(100 %)
2 diff
(99.8 %id)
AI299496 carcinoid, lung .c 6321 to 6735 1 to 415     Submitted on the opposite strand 415/416
(99 %)
1 diff
(99.8 %id)
CB242536 Human Lung Epithelial cells, lung .c 6321 to 7044 742 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 724/724
(100 %)
0 diff
(100 %id)
BQ924245 leiomyosarcoma, uterus .c 6350 to 7035 1 to 686   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 686/686
(100 %)
0 diff
(100 %id)
BF214956 bone marrow, from acute myelogenous leukemia .c 6383 to 7047 1 to 657       657/797
(82 %)
31 diff
(96.2 %id)
CA314202 Human Lung Epithelial cells, lung .c 6383 to 7044 680 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 662/662
(100 %)
0 diff
(100 %id)
AA252020 germinal center B cell .c 6385 to 6508 1 to 124       124/124
(100 %)
1 diff
(99.2 %id)
BE972852 testis .c 6388 to 7021 1 to 639   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 639/639
(100 %)
26 diff
(96.0 %id)
TI_153990110   .c 6388 to 7047 746 to 88       659/747
(88 %)
0 diff
(100 %id)
BM712404 eye, lens .c 6412 to 6915 1 to 504       504/504
(100 %)
0 diff
(100 %id)
BP338184 Spleen .c 6417 to 6974 1 to 558       558/558
(100 %)
0 diff
(100 %id)
AA044334 uterus .c 6435 to 6769 1 to 344       344/348
(98 %)
16 diff
(95.5 %id)
FN116870 breast carcinoma .c 6438 to 6550 1 to 111       111/112
(99 %)
5 diff
(95.6 %id)
BQ023369 placenta .c 6441 to 7044 622 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 604/604
(100 %)
4 diff
(99.4 %id)
AI674191 Prostate .c 6497 to 7034 545 to 8       538/545
(98 %)
0 diff
(100 %id)
BQ023405 placenta .c 6508 to 7044 555 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 537/537
(100 %)
1 diff
(99.9 %id)
BF055314 pooled .c 6509 to 7043 535 to 1       535/535
(100 %)
0 diff
(100 %id)
BQ026073 placenta .c 6522 to 7047 540 to 15       526/540
(97 %)
0 diff
(100 %id)
BQ017243 lung, Metastatic Chondrosarcoma .c 6534 to 7035 520 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 502/502
(100 %)
3 diff
(99.5 %id)
AA043119 uterus .c 6537 to 6689 1 to 153   fully sequenced,   153/153
(100 %)
3 diff
(98.1 %id)
DN911939   .c 6545 to 7044 1 to 500   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 500/500
(100 %)
2 diff
(99.6 %id)
AI632743 Kidney .c 6547 to 7044 498 to 1       498/498
(100 %)
5 diff
(99.0 %id)
AI985151 Kidney .c 6550 to 7047 501 to 4       498/501
(99 %)
0 diff
(100 %id)
AW206076   .c 6552 to 7047 510 to 15       496/510
(97 %)
0 diff
(100 %id)
AI762711 B-cell, chronic lymphotic leukemia .c 6553 to 7035 498 to 15   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 484/485
(99 %)
2 diff
(99.6 %id)
AI635764 Kidney .c 6554 to 7041 500 to 13   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 488/488
(100 %)
0 diff
(100 %id)
BF593886 pooled .c 6565 to 7043 479 to 1       479/479
(100 %)
1 diff
(99.8 %id)
BF108811 pooled .c 6566 to 7043 478 to 1       478/478
(100 %)
1 diff
(99.8 %id)
DB517317 testis .c 6575 to 7044 1 to 472     Submitted on the opposite strand 472/472
(100 %)
26 diff
(94.5 %id)
AI434811 Kidney .c 6583 to 7043 463 to 3       461/463
(99 %)
0 diff
(100 %id)
DB521622 testis .c 6586 to 7044 1 to 459     Submitted on the opposite strand 459/459
(100 %)
0 diff
(100 %id)
BU955541 mixed (pool of 40 RNAs) .c 6591 to 7047 1 to 455       455/484
(94 %)
5 diff
(99.0 %id)
AW044244 pooled .c 6592 to 7047 457 to 2       456/457
(99 %)
0 diff
(100 %id)
AI682376 Prostate .c 6600 to 7044 445 to 1       445/445
(100 %)
0 diff
(100 %id)
AA913643 Kidney .c 6605 to 7045 441 to 1       441/441
(100 %)
0 diff
(100 %id)
R73601 placenta .c 6613 to 7024 419 to 1       419/419
(100 %)
15 diff
(96.5 %id)
R66933 placenta .c 6614 to 7036 435 to 1       435/435
(100 %)
26 diff
(94.1 %id)
R68084 placenta .c 6615 to 7029 437 to 16       422/440
(95 %)
0 diff
(100 %id)
AI942252 Kidney .c 6626 to 7045 421 to 2       420/421
(99 %)
0 diff
(100 %id)
AW028805 fibrotheoma, ovary .c 6626 to 7040 418 to 4       415/418
(99 %)
0 diff
(100 %id)
AA844481 parathyroid gland, parathyroid tumor .c 6628 to 7041 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AA242750 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 6629 to 7044 416 to 1       416/416
(100 %)
0 diff
(100 %id)
AA810327 Ewing's sarcoma .c 6629 to 7047 422 to 4       419/422
(99 %)
0 diff
(100 %id)
R37810 placenta .c 6632 to 7044 431 to 1       431/432
(99 %)
32 diff
(92.6 %id)
AI913004 Kidney .c 6645 to 7035 402 to 11   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 392/392
(100 %)
6 diff
(98.5 %id)
AI640336 Kidney .c 6645 to 7035 401 to 11   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 391/391
(100 %)
3 diff
(99.3 %id)
BF197364 Kidney .c 6646 to 7042 398 to 1       398/398
(100 %)
2 diff
(99.5 %id)
AA401632   .c 6652 to 7042 394 to 4       391/394
(99 %)
0 diff
(100 %id)
AA258873 germinal center B cell .c 6653 to 7047 398 to 4       395/398
(99 %)
0 diff
(100 %id)
AI650247 Kidney .c 6654 to 7044 391 to 1       391/391
(100 %)
0 diff
(100 %id)
AA761105 germinal center B cell .c 6658 to 7047 393 to 4       390/393
(99 %)
0 diff
(100 %id)
AA043120 uterus .c 6659 to 7044 391 to 1   fully sequenced,   391/391
(100 %)
3 diff
(99.3 %id)
AA844631 parathyroid gland, parathyroid tumor .c 6673 to 7047 376 to 2       375/376
(99 %)
0 diff
(100 %id)
EC544155 Prostate .c 6675 to 6780 1 to 109       109/109
(100 %)
3 diff
(97.3 %id)
BE048792 Kidney .c 6677 to 7044 368 to 1       368/368
(100 %)
0 diff
(100 %id)
BE378241 endometrium, adenocarcinoma cell line, uterus .c 6689 to 7041 1 to 353   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 353/353
(100 %)
0 diff
(100 %id)
BE041341 lymph node, lymphoma, follicular mixed small and largecell .c 6702 to 7044 354 to 12   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 343/343
(100 %)
0 diff
(100 %id)
BF512420   .c 6704 to 7034 1 to 331     Submitted on the opposite strand 331/341
(97 %)
4 diff
(98.9 %id)
BF591898 Kidney .c 6704 to 7044 341 to 1       341/341
(100 %)
2 diff
(99.5 %id)
CA313988 Human Lung Epithelial cells, lung .c 6705 to 7035 1 to 331   AAA Submitted on the opposite strand 331/331
(100 %)
3 diff
(99.1 %id)
AA251788 germinal center B cell .c 6709 to 7044 336 to 1       336/336
(100 %)
0 diff
(100 %id)
AA766313 germinal center B cell .c 6712 to 7047 340 to 4       337/340
(99 %)
0 diff
(100 %id)
BF970829 adrenal cortex carcinoma, cell line, adrenal gland .c 6718 to 7033 258 to 579       512/907
(56 %)
24 diff
(97.4 %id)
BE220588 carcinoid, lung .c 6721 to 7025 1 to 305     Submitted on the opposite strand 305/305
(100 %)
1 diff
(99.7 %id)
AU185093 skin .c 6729 to 7034 306 to 1       306/306
(100 %)
0 diff
(100 %id)
AI357701 Kidney, renal cell tumor .c 6735 to 7044 321 to 12   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 310/310
(100 %)
1 diff
(99.7 %id)
AA831213 germinal center B cell .c 6742 to 7044 323 to 21   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 303/303
(100 %)
0 diff
(100 %id)
D62787   .c 6744 to 7044 300 to 1     Submitted on the opposite strand 300/300
(100 %)
6 diff
(98.0 %id)
AI950711 lung, two pooled squamous cell carcinomas .c 6759 to 7043 299 to 13   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 287/287
(100 %)
4 diff
(98.7 %id)
AA913181 Kidney .c 6762 to 7045 284 to 1       284/287
(98 %)
0 diff
(100 %id)
AA031507 uterus .c 6763 to 7047 293 to 7       287/293
(97 %)
0 diff
(100 %id)
AI014863   .c 6765 to 7047 284 to 2       283/284
(99 %)
0 diff
(100 %id)
EC504593 Prostate .c 6771 to 6874 1 to 101       101/102
(99 %)
7 diff
(93.2 %id)
EC547753 Prostate .c 6771 to 6874 1 to 104       104/104
(100 %)
3 diff
(97.2 %id)
EC576847 Prostate .c 6771 to 6874 1 to 100       100/100
(100 %)
7 diff
(93.0 %id)
AA760880 germinal center B cell .c 6780 to 7047 271 to 4       268/271
(98 %)
0 diff
(100 %id)
BP420326 small intestine .c 6787 to 7039 1 to 253     Submitted on the opposite strand 253/253
(100 %)
1 diff
(99.7 %id)
AI364439 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 6792 to 7046 255 to 1       255/255
(100 %)
1 diff
(99.7 %id)
EC567692 Prostate .c 6826 to 6924 1 to 99       99/102
(97 %)
1 diff
(99.1 %id)
AW075353 colon, juvenile granulosa tumor .c 6833 to 7044 214 to 1       214/239
(89 %)
4 diff
(98.4 %id)
AI027094 parathyroid gland, parathyroid tumor .c 6870 to 7035 179 to 14   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 166/166
(100 %)
0 diff
(100 %id)
EC557232 Prostate .c 6885 to 6994 1 to 113       113/117
(96 %)
7 diff
(94.1 %id)
BM146199 leukopheresis .d -11 to 337 1 to 349   tiling clone,   349/349
(100 %)
7 diff
(98.0 %id)
DB225492 trachea .d 1 to 562 5 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
BY799594 eye .d 2 to 227 1 to 226       226/226
(100 %)
0 diff
(100 %id)
BP219488 caudate nucleus .d 25 to 606 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA952559 Spleen .d 27 to 508 2 to 483   capped   482/482
(100 %)
0 diff
(100 %id)
DA990037 synovial membrane tissue from rheumatioidarthritis .d 27 to 562 2 to 537   tiling clone, capped   536/536
(100 %)
0 diff
(100 %id)
AI970547 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 38 to 209 172 to 1       172/172
(100 %)
4 diff
(97.7 %id)
BE672419 pooled germ cell tumors .d 39 to 235 197 to 1       197/197
(100 %)
1 diff
(99.5 %id)
AA580185 breast .d 40 to 190 151 to 1       151/151
(100 %)
4 diff
(97.4 %id)
AW003357 pooled germ cell tumors .d 56 to 209 154 to 1       154/154
(100 %)
1 diff
(99.4 %id)
AW025805 pooled germ cell tumors .d 56 to 235 180 to 1       180/180
(100 %)
1 diff
(99.5 %id)
ES315649 occipital scalp hair, skin .d 71 to 151 1 to 81       81/89
(91 %)
1 diff
(98.9 %id)
AA258265 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 228 to 626 1 to 392     Submitted on the opposite strand 392/392
(100 %)
10 diff
(97.5 %id)
AI199981 lung .d 228 to 633 1 to 406     Submitted on the opposite strand 406/406
(100 %)
1 diff
(99.8 %id)
AI382488 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 228 to 401 1 to 173     Submitted on the opposite strand 173/218
(79 %)
3 diff
(98.7 %id)
AA954300 pooled .d 229 to 638 1 to 406     Submitted on the opposite strand 406/406
(100 %)
5 diff
(98.8 %id)
AW452579   .d 229 to 623 1 to 397     Submitted on the opposite strand 397/397
(100 %)
2 diff
(99.5 %id)
AI492421 Kidney .d 246 to 769 1 to 524     Submitted on the opposite strand 524/524
(100 %)
2 diff
(99.7 %id)
AI436161 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 247 to 636 1 to 390     Submitted on the opposite strand 390/390
(100 %)
2 diff
(99.5 %id)
AW118980 pooled .d 263 to 731 1 to 469     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
AI910389 colon, colon tumor, RER+ .d 269 to 610 1 to 342     Submitted on the opposite strand 342/342
(100 %)
1 diff
(99.8 %id)
AA418471 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 292 to 761 468 to 1     Submitted on the opposite strand 468/468
(100 %)
6 diff
(98.8 %id)
H82085 melanocyte .d 296 to 540 1 to 256   fully sequenced, Submitted on the opposite strand 256/256
(100 %)
8 diff
(96.9 %id)
TI_2194579593   .d 381 to 1581 35 to 1226       1194/1269
(94 %)
34 diff
(97.4 %id)
BC143251 Brain, cerebral cortex, PCR rescued clones .d 389 to 3144 1 to 2754 L79* tiling clone,   2756/2754
(100 %)
6 diff
(99.8 %id)
AA258264 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 393 to 754 369 to 1     Submitted on the opposite strand 366/369
(99 %)
10 diff
(97.3 %id)
R76416 placenta .d 400 to 709 112 to 421     Submitted on the opposite strand 310/430
(72 %)
8 diff
(98.2 %id)
N36717 melanocyte .d 400 to 729 335 to 1     Submitted on the opposite strand 335/395
(84 %)
4 diff
(99.0 %id)
W79736 heart .d 400 to 766 368 to 1     Submitted on the opposite strand 368/387
(95 %)
1 diff
(99.8 %id)
AF323730   .d 401 to 2156 414 to 2169   tiling clone,   2169/2169
(100 %)
1 diff
(100.0 %id)
NM_001003712.1   .d 401 to 7180 414 to 7193 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 7193/7193
(100 %)
0 diff
(100 %id)
TI_2194579086   .d 423 to 1589 1 to 1152       1154/1270
(90 %)
34 diff
(97.4 %id)
H82191 melanocyte .d 479 to 733 256 to 1   fully sequenced, Submitted on the opposite strand 256/256
(100 %)
1 diff
(99.7 %id)
TI_891530318   .d 504 to 1589 1096 to 25       1072/1221
(87 %)
14 diff
(98.9 %id)
BE695592 breast .d 552 to 1150 609 to 11       599/609
(98 %)
3 diff
(99.6 %id)
TI_891529812   .d 591 to 1675 1 to 1081       1081/1262
(85 %)
12 diff
(99.1 %id)
TI_927047707   .d 595 to 1778 10 to 1189       1180/1284
(91 %)
7 diff
(99.5 %id)
TI_2194579087   .d 599 to 1659 14 to 1063       1052/1243
(84 %)
21 diff
(98.4 %id)
BG314927   .d 615 to 852 239 to 1       239/239
(100 %)
2 diff
(99.2 %id)
BX472472   .d 638 to 1198 49 to 609       561/609
(92 %)
7 diff
(98.9 %id)
BX474022   .d 647 to 1164 1 to 518       518/518
(100 %)
0 diff
(100 %id)
AL708610 human skeletal muscle .d 699 to 1228 1 to 530       530/530
(100 %)
0 diff
(100 %id)
BF766720 colon_est .d 733 to 955 1 to 224       224/378
(59 %)
7 diff
(98.2 %id)
AL704645 human skeletal muscle .d 762 to 1363 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
T05874   .d 785 to 1059 1 to 276       276/276
(100 %)
1 diff
(99.7 %id)
AL707486 human skeletal muscle .d 827 to 1481 28 to 681       654/681
(96 %)
10 diff
(98.6 %id)
N31283 melanocyte .d 834 to 1287 454 to 1     Submitted on the opposite strand 454/455
(99 %)
0 diff
(100 %id)
BU517216 leiomyosarcoma, uterus .d 857 to 1698 1 to 865       865/881
(98 %)
22 diff
(97.6 %id)
DA816684   .d 859 to 1418 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
AW747991 breast .d 920 to 1375 1 to 455       455/455
(100 %)
6 diff
(98.7 %id)
DA337040 hippocampus .d 927 to 1517 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
BF332968 breast .d 956 to 1248 301 to 9       293/301
(97 %)
0 diff
(100 %id)
TI_927047699   .d 1017 to 2245 11 to 1221       1211/1258
(96 %)
35 diff
(97.3 %id)
TI_2194579079   .d 1017 to 2052 12 to 1046       1035/1264
(81 %)
8 diff
(99.4 %id)
TI_891529804   .d 1021 to 2148 14 to 1128       1117/1252
(89 %)
24 diff
(98.1 %id)
AA873730 pooled germ cell tumors .d 1084 to 1402 1 to 321     Submitted on the opposite strand 321/321
(100 %)
14 diff
(95.7 %id)
AA766570 germinal center B cell .d 1085 to 1403 9 to 327     Submitted on the opposite strand 319/319
(100 %)
0 diff
(100 %id)
BP234624 coronary artery .d 1092 to 1659 17 to 583       571/583
(97 %)
12 diff
(98.0 %id)
BP283659 bone marrow .d 1236 to 1819 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
DN989271 brain, whole brain .d 1239 to 1850 1 to 612       612/612
(100 %)
5 diff
(99.2 %id)
TI_2194579080   .d 1253 to 2326 1 to 1067       1067/1224
(87 %)
17 diff
(98.7 %id)
TI_891529805   .d 1266 to 2404 5 to 1140       1136/1246
(91 %)
16 diff
(98.8 %id)
TI_927047700   .d 1267 to 2409 16 to 1152       1137/1262
(90 %)
16 diff
(98.8 %id)
AW748009 breast .d 1269 to 1375 8 to 114       107/114
(93 %)
6 diff
(94.8 %id)
BP290921 lung .d 1376 to 1847 1 to 472       472/580
(81 %)
9 diff
(98.5 %id)
CB269563 adipose .d 1389 to 1685 37 to 333       297/333
(89 %)
7 diff
(97.9 %id)
DB040424 testis .d 1438 to 1993 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DR001474 fetal brain .d 1497 to 2246 10 to 759       750/759
(98 %)
7 diff
(99.1 %id)
BM510273 insulinoma, Pancreas .d 1511 to 2068 1 to 558       558/558
(100 %)
5 diff
(99.2 %id)
TI_927047701   .d 1565 to 2750 1 to 1182       1182/1283
(92 %)
12 diff
(99.1 %id)
TI_2194579081   .d 1565 to 2661 1 to 1086       1086/1263
(85 %)
21 diff
(98.4 %id)
TI_891529806   .d 1567 to 2711 1 to 1134       1134/1265
(89 %)
27 diff
(97.9 %id)
BQ305629 breast .d 1571 to 2052 1 to 482       482/504
(95 %)
6 diff
(98.9 %id)
BQ225396 leiomyosarcoma, uterus .d 1622 to 2464 24 to 874       851/1024
(83 %)
24 diff
(97.7 %id)
CD642784 Embryonic Stem cells .d 1684 to 2474 1 to 784       784/816
(96 %)
17 diff
(98.0 %id)
BP354614   .d 1755 to 2331 1 to 579       579/582
(99 %)
5 diff
(99.2 %id)
TI_891529807   .d 1855 to 3054 7 to 1189       1186/1268
(93 %)
33 diff
(97.4 %id)
TI_2194579082   .d 1855 to 3125 14 to 1267       1253/1270
(98 %)
38 diff
(97.1 %id)
TI_927047702   .d 1866 to 2968 19 to 1110       1092/1263
(86 %)
18 diff
(98.6 %id)
AL832876 lymph node .d 1886 to 7177 1 to 5290   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 5290/5290
(100 %)
3 diff
(100.0 %id)
DB215614 trachea .d 1941 to 2493 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BC012935 Colon, adenocarcinoma .d 1957 to 3632 1 to 1676   available from MGC, AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 1676/1676
(100 %)
0 diff
(100 %id)
BE869990 adenocarcinoma, colon .d 1978 to 2714 1 to 736   available from MGC,   736/736
(100 %)
7 diff
(99.1 %id)
TI_891529977   .d 2071 to 3154 1141 to 72     Submitted on the opposite strand 1073/1271
(84 %)
16 diff
(98.8 %id)
TI_2194579083   .d 2073 to 3155 1 to 1080       1080/1270
(85 %)
12 diff
(99.1 %id)
TI_927047703   .d 2074 to 3154 1 to 1080       1080/1256
(85 %)
9 diff
(99.3 %id)
TI_891529808   .d 2076 to 3154 1 to 1072       1072/1271
(84 %)
17 diff
(98.7 %id)
DR763042 embryonic stem .d 2081 to 2781 1 to 701       701/701
(100 %)
3 diff
(99.6 %id)
CN373527 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 2082 to 2855 1 to 774       774/775
(99 %)
5 diff
(99.4 %id)
TI_2194579598   .d 2107 to 3155 1086 to 42       1045/1276
(81 %)
8 diff
(99.4 %id)
AA282609 germinal center B cell .d 2139 to 2565 1 to 427       427/427
(100 %)
0 diff
(100 %id)
TI_927047520   .d 2151 to 3154 1043 to 56     Submitted on the opposite strand 948/1165
(81 %)
17 diff
(98.6 %id)
DA212941 brain .d 2161 to 2730 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
AL601758   .d 2201 to 2729 1 to 529       529/529
(100 %)
24 diff
(95.5 %id)
DA732829   .d 2220 to 2855 2 to 638   capped   637/659
(96 %)
7 diff
(99.0 %id)
BM508099 insulinoma, Pancreas .d 2282 to 2880 615 to 17   AAA   599/599
(100 %)
1 diff
(99.9 %id)
EC485159 Prostate .d 2318 to 2431 1 to 112       112/112
(100 %)
4 diff
(96.5 %id)
BQ575484 Chondrosarcoma Grade II, Left Pelvis .d 2357 to 2945 608 to 19   AAA   590/590
(100 %)
2 diff
(99.7 %id)
DA735167   .d 2359 to 3184 2 to 827   capped   826/826
(100 %)
6 diff
(99.3 %id)
BP423201 small intestine .d 2372 to 2875 1 to 505     Submitted on the opposite strand 505/505
(100 %)
2 diff
(99.7 %id)
DB327693   .d 2374 to 2945 572 to 1       572/572
(100 %)
0 diff
(100 %id)
AW945786 lung_normal .d 2398 to 2742 1 to 345       345/345
(100 %)
9 diff
(97.4 %id)
DA246277 brain .d 2405 to 2984 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
AK172813   .d 2442 to 5662 1 to 3221   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 3221/3221
(100 %)
1 diff
(100.0 %id)
DA759913   .d 2450 to 3000 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
TI_2194579084   .d 2539 to 3155 1 to 614       614/1208
(50 %)
7 diff
(99.5 %id)
TI_927047704   .d 2543 to 3154 1 to 611       611/1265
(48 %)
6 diff
(99.6 %id)
TI_891529809   .d 2544 to 3154 1 to 608       608/1217
(49 %)
7 diff
(99.5 %id)
DB337787 testis .d 2568 to 3091 524 to 1       524/524
(100 %)
0 diff
(100 %id)
BG168525 hypernephroma, cell line, Kidney .d 2607 to 3324 1 to 734       734/1168
(62 %)
27 diff
(97.7 %id)
BM149633 leukopheresis .d 2644 to 3190 563 to 17   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 547/547
(100 %)
7 diff
(98.8 %id)
CF995248 Human Placenta, placenta .d 2680 to 3463 23 to 811       789/835
(94 %)
13 diff
(98.5 %id)
BX474377   .d 2691 to 3224 8 to 538       531/538
(98 %)
10 diff
(98.2 %id)
BQ962026 leiomyosarcoma, uterus .d 2705 to 3541 1 to 848       848/893
(94 %)
15 diff
(98.4 %id)
AA282512 germinal center B cell .d 2733 to 2945 213 to 1       213/213
(100 %)
0 diff
(100 %id)
BG196426   .d 2753 to 3008 14 to 267       254/267
(95 %)
6 diff
(97.8 %id)
TI_891529810   .d 2819 to 3154 13 to 347       335/1245
(26 %)
7 diff
(99.5 %id)
CD641215 pooled .d 2837 to 3517 1 to 681       681/681
(100 %)
4 diff
(99.5 %id)
BM468404 leiomyosarcoma, uterus .d 2859 to 3866 1 to 1014       1014/1018
(99 %)
20 diff
(98.1 %id)
BX480799   .d 2877 to 3314 1 to 438       438/438
(100 %)
1 diff
(99.8 %id)
AL699881 human skeletal muscle .d 2885 to 3519 1 to 635       635/635
(100 %)
2 diff
(99.7 %id)
DA148055 amygdala .d 2889 to 3460 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
AA352298   .d 2921 to 3263 9 to 351       343/358
(95 %)
1 diff
(99.8 %id)
AL049923 brain .d 2946 to 5662 1 to 2717   available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2717/2717
(100 %)
1 diff
(100.0 %id)
DA490568 brain .d 2952 to 3504 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
CD642987 Embryonic Stem cells .d 2975 to 3702 42 to 764       723/796
(90 %)
6 diff
(99.3 %id)
BG314882   .d 2978 to 3124 147 to 1       147/147
(100 %)
4 diff
(97.3 %id)
DA390526 thalamus .d 2983 to 3557 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB183230 liver, tumor tissue .d 2986 to 3463 2 to 481   capped   480/499
(96 %)
8 diff
(98.4 %id)
AW673088 cervix .d 2990 to 3321 1 to 333       333/333
(100 %)
2 diff
(99.4 %id)
BG314976   .d 3012 to 3124 104 to 217       114/120
(95 %)
4 diff
(96.7 %id)
AW242021 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 3030 to 3384 357 to 3       355/357
(99 %)
0 diff
(100 %id)
AL601519   .d 3043 to 3577 1 to 534       534/534
(100 %)
1 diff
(99.9 %id)
BP243217 Liver .d 3066 to 3645 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
GD148086   .d 3080 to 3202 1 to 123       123/126
(97 %)
5 diff
(96.1 %id)
C01470   .d 3125 to 3218 1 to 94       94/94
(100 %)
0 diff
(100 %id)
EC452990 Prostate .d 3149 to 3272 120 to 1       120/120
(100 %)
4 diff
(96.7 %id)
EC496412 Prostate .d 3149 to 3272 123 to 1       123/123
(100 %)
1 diff
(99.2 %id)
EC526145 Prostate .d 3149 to 3272 120 to 1       120/120
(100 %)
4 diff
(96.7 %id)
EC554595 Prostate .d 3149 to 3272 118 to 1       118/118
(100 %)
4 diff
(96.7 %id)
EC569177 Prostate .d 3149 to 3272 122 to 1       122/122
(100 %)
2 diff
(98.4 %id)
BU429838 lymph .d 3164 to 3372 230 to 22   AAA Submitted on the opposite strand 209/209
(100 %)
0 diff
(100 %id)
BM454764 leiomyosarcoma, uterus .d 3182 to 4051 1 to 880       880/1127
(78 %)
26 diff
(97.7 %id)
BG503241 embryonal carcinoma, testis .d 3184 to 3527 1 to 346       346/412
(83 %)
3 diff
(99.3 %id)
DA569720 whole embryo, mainly head .d 3188 to 4043 2 to 852   capped   851/855
(99 %)
11 diff
(98.8 %id)
BP238055 Liver .d 3197 to 3797 1 to 601       601/601
(100 %)
3 diff
(99.6 %id)
AA330358   .d 3289 to 3497 1 to 209       209/209
(100 %)
0 diff
(100 %id)
BM829539 Ascites, stomach .d 3303 to 3920 1 to 618       618/618
(100 %)
0 diff
(100 %id)
BI335579 cervical carcinoma cell line, cervix .d 3306 to 3778 27 to 494       468/495
(94 %)
14 diff
(97.2 %id)
DA727268   .d 3314 to 3891 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
BU169993 embryonal carcinoma, cell line, testis .d 3318 to 4011 35 to 737       703/971
(72 %)
26 diff
(97.4 %id)
BP238563 Liver .d 3330 to 3915 1 to 588       588/614
(95 %)
25 diff
(96.0 %id)
DB198358 trachea .d 3429 to 3912 2 to 486   capped   485/485
(100 %)
1 diff
(99.8 %id)
DA181997 amygdala .d 3446 to 4003 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
Z78381 brain .d 3457 to 4177 1 to 727       727/727
(100 %)
15 diff
(98.0 %id)
DA308684 hippocampus .d 3476 to 4054 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BP207149 coronary artery .d 3522 to 4105 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
DA231354 brain .d 3563 to 4104 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
AL712413 human skeletal muscle .d 3604 to 4100 1 to 497       497/497
(100 %)
0 diff
(100 %id)
BF030954 hypernephroma, Kidney .d 3632 to 4284 1 to 657       657/688
(95 %)
25 diff
(96.4 %id)
DA238661 brain .d 3696 to 4288 2 to 594   capped   593/595
(99 %)
1 diff
(99.9 %id)
DA031114   .d 3719 to 4235 2 to 519   capped   518/518
(100 %)
1 diff
(99.9 %id)
BG897091 cartilage .d 3726 to 4093 83 to 451       369/383
(96 %)
6 diff
(98.5 %id)
DA183697 amygdala .d 3740 to 4289 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BP277128 Kidney .d 3741 to 4311 1 to 575       575/582
(98 %)
19 diff
(96.8 %id)
DA645388   .d 3742 to 4332 2 to 592   capped   591/591
(100 %)
3 diff
(99.5 %id)
DA817570   .d 3742 to 4318 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB165613 thymus .d 3742 to 4348 2 to 609   capped   608/608
(100 %)
1 diff
(99.9 %id)
DA085189 cerebellum .d 3744 to 4313 2 to 573   capped   572/572
(100 %)
4 diff
(99.4 %id)
BP289859 lung .d 3745 to 4331 1 to 587       587/587
(100 %)
6 diff
(99.0 %id)
BP290684 lung .d 3746 to 4328 1 to 583       583/584
(99 %)
8 diff
(98.7 %id)
BM828497 Ascites, stomach .d 3778 to 4376 1 to 599       599/599
(100 %)
5 diff
(99.2 %id)
BM457471 embryonal carcinoma, cell line, testis .d 3830 to 4689 41 to 902       862/1140
(75 %)
27 diff
(97.7 %id)
BX499744 Liver .d 3835 to 4403 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
BP290706 lung .d 3847 to 4425 1 to 582       582/582
(100 %)
6 diff
(99.0 %id)
DA616966   .d 3889 to 4484 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
BP327158 prostata .d 3893 to 4325 1 to 433       433/583
(74 %)
12 diff
(98.0 %id)
BP291103 lung .d 3915 to 4469 1 to 557       557/557
(100 %)
2 diff
(99.7 %id)
BU509791 leiomyosarcoma, uterus .d 3966 to 4619 1 to 659       659/829
(79 %)
7 diff
(99.2 %id)
DA807193 brain .d 4014 to 4570 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DN918498   .d 4032 to 4663 1 to 632       632/632
(100 %)
2 diff
(99.7 %id)
DN918572   .d 4032 to 4529 1 to 498       498/498
(100 %)
2 diff
(99.6 %id)
AW952899   .d 4046 to 4532 1 to 487       487/488
(99 %)
5 diff
(99.0 %id)
BP360643 thalamus .d 4058 to 4651 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
BE889712 leiomyosarcoma, uterus .d 4071 to 4836 1 to 773       773/985
(78 %)
29 diff
(97.1 %id)
BG570000 lung .d 4080 to 4805 1 to 733       733/806
(90 %)
23 diff
(97.2 %id)
BM545208 brain, hippocampus .d 4080 to 5125 1 to 1057       1057/1057
(100 %)
44 diff
(95.9 %id)
BM452566 lymph, lymphoma, cell line .d 4081 to 4627 1 to 553   AAA   553/1161
(47 %)
54 diff
(95.4 %id)
DB162749 thymus .d 4113 to 4685 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
AA262672 germinal center B cell .d 4114 to 4520 1 to 407       407/407
(100 %)
0 diff
(100 %id)
DN918497   .d 4120 to 4852 722 to 1       722/722
(100 %)
15 diff
(98.0 %id)
BI092945 cervix .d 4152 to 4936 1 to 788       788/789
(99 %)
14 diff
(98.3 %id)
BX491741   .d 4168 to 4723 1 to 556       556/556
(100 %)
2 diff
(99.7 %id)
DA570582 whole embryo, mainly head .d 4172 to 4835 2 to 665   capped   664/746
(89 %)
3 diff
(99.6 %id)
AW166062 brain, medulloblastoma .d 4207 to 4585 1 to 380     Submitted on the opposite strand 380/380
(100 %)
5 diff
(98.7 %id)
DN918573   .d 4263 to 4754 490 to 1       490/491
(99 %)
7 diff
(98.6 %id)
DA712069   .d 4285 to 4821 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
FN176163 breast carcinoma .d 4288 to 4414 127 to 1     Submitted on the opposite strand 127/127
(100 %)
0 diff
(100 %id)
AA721396 germinal center B cell .d 4318 to 4609 1 to 292     Submitted on the opposite strand 292/292
(100 %)
2 diff
(99.4 %id)
AW976699   .d 4328 to 4903 1 to 583       583/588
(99 %)
17 diff
(97.2 %id)
BF795558 lymph, lymphoma, cell line .d 4332 to 4966 1 to 634       634/634
(100 %)
3 diff
(99.6 %id)
BP290020 lung .d 4378 to 4925 1 to 548       548/583
(93 %)
14 diff
(97.6 %id)
CN373532 embryonic stem cells, DMSO-treated H9 cellline .d 4395 to 4869 1 to 475       475/475
(100 %)
1 diff
(99.8 %id)
CB164449 Liver .d 4407 to 5007 1 to 601       601/601
(100 %)
0 diff
(100 %id)
CN373531 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 4470 to 4869 1 to 400       400/400
(100 %)
0 diff
(100 %id)
CB053397 leiomyosarcoma, soft tissue .d 4509 to 5139 1 to 631       631/631
(100 %)
5 diff
(99.3 %id)
AF173895 normal aorta .d 4516 to 7171 1 to 2653   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2653/2653
(100 %)
2 diff
(100.0 %id)
DB364470   .d 4519 to 5027 507 to 1       507/515
(98 %)
11 diff
(97.9 %id)
AA746002 germinal center B cell .d 4535 to 4647 1 to 113     Submitted on the opposite strand 113/113
(100 %)
0 diff
(100 %id)
DA748623   .d 4561 to 5138 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
EH340696   .d 4589 to 4677 1 to 90       90/91
(98 %)
5 diff
(94.6 %id)
FN128730 breast carcinoma .d 4603 to 4689 1 to 85       85/85
(100 %)
4 diff
(95.3 %id)
BE566230 bladder, carcinoma, cell line .d 4606 to 5215 1 to 611       611/611
(100 %)
7 diff
(98.9 %id)
BF700981 brain, primitive neuroectoderm .d 4637 to 5313 1 to 665       665/861
(77 %)
27 diff
(96.9 %id)
BX502298 Liver .d 4646 to 5150 14 to 520       507/520
(97 %)
6 diff
(98.9 %id)
BX482162   .d 4649 to 5182 1 to 534       534/534
(100 %)
0 diff
(100 %id)
BQ720949 sympathetic trunk .d 4668 to 5474 1 to 815       815/891
(91 %)
16 diff
(98.3 %id)
DA886437   .d 4686 to 5256 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
TI_59393125   .d 4703 to 5626 84 to 1011       928/932
(99 %)
38 diff
(96.0 %id)
BM015022 breast, mammary adenocarcinoma, cell line .d 4704 to 5626 1 to 927       927/931
(99 %)
38 diff
(96.0 %id)
DB194792 trachea .d 4704 to 5222 2 to 521   capped   520/520
(100 %)
1 diff
(99.9 %id)
BX502443 Liver .d 4712 to 5341 1 to 630       630/630
(100 %)
3 diff
(99.6 %id)
BQ631719 Pancreas, Purified pancreatic islet .d 4757 to 5203 1 to 447   fully sequenced,   447/447
(100 %)
0 diff
(100 %id)
BF542056 hypernephroma, Kidney .d 4764 to 5464 1 to 702   AAA   702/830
(84 %)
29 diff
(96.6 %id)
BG290077 bladder, transitional cell papilloma, cell line .d 4810 to 5522 1 to 710       710/718
(98 %)
9 diff
(98.8 %id)
EB386411 eye, optic nerve .d 4821 to 5438 1 to 618       618/618
(100 %)
0 diff
(100 %id)
H15742 breast .d 4835 to 5189 1 to 366       366/489
(74 %)
16 diff
(96.8 %id)
BG169323 hypernephroma, cell line, Kidney .d 4856 to 5626 1 to 756       756/915
(82 %)
19 diff
(98.0 %id)
CA777252 Pancreas, Purified pancreatic islet .d 4858 to 5229 7 to 378   fully sequenced,   372/378
(98 %)
5 diff
(98.7 %id)
DB113218 thymus .d 4858 to 5431 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BU521929 leiomyosarcoma, uterus .d 4861 to 5683 1 to 826       826/827
(99 %)
8 diff
(99.1 %id)
BU902190 leiomyosarcoma, uterus .d 4867 to 5578 1 to 716       716/1287
(55 %)
19 diff
(98.6 %id)
DA708533   .d 4874 to 5437 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
BG107818 Bone, osteosarcoma, cell line .d 4878 to 5659 1 to 764   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 764/764
(100 %)
62 diff
(91.9 %id)
DB110183 thymus .d 4897 to 5461 2 to 566   capped   565/567
(99 %)
1 diff
(99.9 %id)
DA176828 amygdala .d 4901 to 5415 2 to 516   capped   515/515
(100 %)
0 diff
(100 %id)
CA841214 Pancreas, Purified pancreatic islet .d 4909 to 5226 1 to 318       318/318
(100 %)
3 diff
(99.1 %id)
BP326207 prostata .d 4943 to 5514 1 to 571       571/571
(100 %)
1 diff
(99.9 %id)
BE883870 leiomyosarcoma, uterus .d 4947 to 5555 1 to 609       609/885
(68 %)
6 diff
(99.4 %id)
FN166929 breast carcinoma .d 4958 to 5073 121 to 1     Submitted on the opposite strand 121/126
(96 %)
5 diff
(96.1 %id)
CA415449 Chondrosarcoma Grade II, Left Pelvis .d 4962 to 5662 718 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 700/700
(100 %)
1 diff
(99.9 %id)
CN399348 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 4965 to 5474 1 to 510       510/510
(100 %)
0 diff
(100 %id)
BP292939 lung .d 4969 to 5550 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA886335   .d 4986 to 5534 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
AV707016 adrenal gland .d 5049 to 5673 1 to 625       625/685
(91 %)
7 diff
(99.0 %id)
AA193504 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 5053 to 5665 1 to 609       609/609
(100 %)
7 diff
(98.9 %id)
AA126551 uterus .d 5054 to 5297 1 to 245       245/245
(100 %)
1 diff
(99.6 %id)
AW663667 pooled .d 5060 to 5527 1 to 468     Submitted on the opposite strand 468/468
(100 %)
0 diff
(100 %id)
BP366362   .d 5086 to 5667 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DB356411 whole embryo, mainly head .d 5109 to 5662 555 to 1       555/561
(98 %)
9 diff
(98.4 %id)
DA573013 whole embryo, mainly body .d 5110 to 5757 2 to 648   capped   647/651
(99 %)
5 diff
(99.3 %id)
DB357365 whole embryo, mainly head .d 5120 to 5662 539 to 1       539/539
(100 %)
7 diff
(98.8 %id)
AW292007   .d 5120 to 5532 1 to 413     Submitted on the opposite strand 413/413
(100 %)
6 diff
(98.6 %id)
AA721301 germinal center B cell .d 5126 to 5449 1 to 324     Submitted on the opposite strand 324/324
(100 %)
1 diff
(99.7 %id)
DA732717   .d 5127 to 5697 11 to 580   capped   570/579
(98 %)
2 diff
(99.7 %id)
AI935402 Kidney .d 5135 to 5598 1 to 464     Submitted on the opposite strand 464/469
(98 %)
11 diff
(97.7 %id)
AW105022 pooled .d 5135 to 5601 1 to 467     Submitted on the opposite strand 467/467
(100 %)
0 diff
(100 %id)
AW235677 Kidney .d 5135 to 5568 1 to 434     Submitted on the opposite strand 434/434
(100 %)
5 diff
(98.9 %id)
N63478 multiple sclerosis lesions .d 5140 to 5601 1 to 471     Submitted on the opposite strand 471/482
(97 %)
17 diff
(96.5 %id)
DB367368   .d 5141 to 5662 519 to 1       519/520
(99 %)
16 diff
(97.0 %id)
BP332269 renal proximal tubule .d 5143 to 5700 1 to 557       557/557
(100 %)
9 diff
(98.4 %id)
AA707415   .d 5145 to 5654 510 to 1     Submitted on the opposite strand 510/510
(100 %)
7 diff
(98.7 %id)
BI522842 brain .d 5147 to 5783 1 to 635       635/863
(73 %)
11 diff
(98.8 %id)
TI_44185882   .d 5148 to 5783 30 to 663   AAA   634/862
(73 %)
6 diff
(99.4 %id)
CV572335 cornea, eye .d 5170 to 5458 1 to 289       289/289
(100 %)
0 diff
(100 %id)
AI634817 Kidney .d 5173 to 5673 501 to 1       501/501
(100 %)
0 diff
(100 %id)
BQ632017 Pancreas, Purified pancreatic islet .d 5173 to 5662 490 to 1   fully sequenced,   490/490
(100 %)
0 diff
(100 %id)
AI985366 Kidney .d 5180 to 5662 483 to 1       483/483
(100 %)
1 diff
(99.8 %id)
BF001155 Prostate .d 5189 to 5673 485 to 1       485/485
(100 %)
2 diff
(99.6 %id)
AW967965   .d 5192 to 5661 469 to 1     Submitted on the opposite strand 469/472
(99 %)
16 diff
(96.7 %id)
D79891 aorta .d 5192 to 5550 1 to 359       359/359
(100 %)
1 diff
(99.8 %id)
AI379490 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 5192 to 5662 471 to 1       471/471
(100 %)
0 diff
(100 %id)
CA776965 Pancreas, Purified pancreatic islet .d 5199 to 5662 465 to 1   fully sequenced,   465/465
(100 %)
9 diff
(98.1 %id)
FN136100 breast carcinoma .d 5200 to 5285 1 to 87       87/87
(100 %)
1 diff
(98.9 %id)
BG427257 Kidney .d 5201 to 5733 1 to 538       538/644
(83 %)
16 diff
(97.6 %id)
BP289617 lung .d 5209 to 5789 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
AA708727 uterus .d 5211 to 5662 452 to 1       452/452
(100 %)
2 diff
(99.6 %id)
AI223048 pooled .d 5219 to 5664 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AI269907 Kidney .d 5227 to 5662 437 to 1       437/437
(100 %)
1 diff
(99.8 %id)
AI718107 aorta .d 5229 to 5665 437 to 1       437/437
(100 %)
1 diff
(99.8 %id)
AA856756 germinal center B cell .d 5232 to 5672 441 to 1       441/441
(100 %)
2 diff
(99.6 %id)
AA928001 pooled .d 5232 to 5662 430 to 1       430/430
(100 %)
1 diff
(99.8 %id)
N87034   .d 5233 to 5489 1 to 258       258/258
(100 %)
19 diff
(92.7 %id)
AI674066 pooled .d 5235 to 5581 359 to 13       347/359
(96 %)
0 diff
(100 %id)
BM466118 embryonal carcinoma, cell line, testis .d 5238 to 6183 1 to 952       952/1109
(85 %)
46 diff
(95.9 %id)
AI676259 adenocarcinoma, Pancreas .d 5245 to 5662 418 to 1       418/418
(100 %)
0 diff
(100 %id)
AW673724 cervix .d 5247 to 5660 416 to 3       414/416
(99 %)
0 diff
(100 %id)
N94776 multiple sclerosis lesions .d 5249 to 5686 448 to 11     Submitted on the opposite strand 438/448
(97 %)
4 diff
(99.2 %id)
DA279791 corpus callosum .d 5252 to 5749 2 to 497   capped   496/496
(100 %)
3 diff
(99.4 %id)
BP293860 lung .d 5253 to 5833 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BQ019116 lung, Metastatic Chondrosarcoma .d 5254 to 5662 427 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 409/409
(100 %)
0 diff
(100 %id)
AI858394 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 5262 to 5665 404 to 1       404/404
(100 %)
1 diff
(99.8 %id)
AA767567 germinal center B cell .d 5266 to 5531 1 to 266     Submitted on the opposite strand 266/266
(100 %)
0 diff
(100 %id)
BI094483 cervix .d 5270 to 5682 35 to 449       415/780
(53 %)
6 diff
(99.3 %id)
AW674598 cervix .d 5273 to 5663 391 to 1       391/391
(100 %)
0 diff
(100 %id)
AA099772 colon, tumor .d 5284 to 5664 384 to 1     Submitted on the opposite strand 384/384
(100 %)
5 diff
(98.7 %id)
H15743 breast .d 5292 to 5662 379 to 1       379/408
(92 %)
14 diff
(96.6 %id)
AW515071 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 5303 to 5665 363 to 1       363/363
(100 %)
0 diff
(100 %id)
AW674523 cervix .d 5305 to 5663 359 to 1       359/359
(100 %)
12 diff
(96.7 %id)
AA928227 pharynx, squamous cell carcinoma .d 5308 to 5614 307 to 1       307/307
(100 %)
1 diff
(99.7 %id)
AW103273 pooled .d 5308 to 5663 359 to 1       359/359
(100 %)
4 diff
(98.9 %id)
AW515004 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 5311 to 5665 355 to 1       355/355
(100 %)
0 diff
(100 %id)
AA601903   .d 5313 to 5672 360 to 1       360/360
(100 %)
3 diff
(99.2 %id)
AA652787   .d 5330 to 5671 342 to 1       342/342
(100 %)
4 diff
(98.9 %id)
AA136016 uterus .d 5344 to 5657 319 to 6       314/320
(98 %)
0 diff
(100 %id)
BM751323 Ascites, stomach .d 5363 to 5883 1 to 522       522/522
(100 %)
7 diff
(98.7 %id)
BU607905 Human Lung Epithelial cells, lung .d 5369 to 5662 312 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 294/390
(75 %)
1 diff
(99.8 %id)
CA840956 Pancreas, Purified pancreatic islet .d 5373 to 5662 290 to 1       290/290
(100 %)
4 diff
(98.7 %id)
AI460247 colon .d 5402 to 5662 261 to 1       261/261
(100 %)
0 diff
(100 %id)
AW021865 cochlea, ear .d 5404 to 5662 8 to 266   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 259/266
(97 %)
6 diff
(97.8 %id)
BI492795 cochlea, ear .d 5443 to 5678 236 to 1   fully sequenced, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 236/236
(100 %)
3 diff
(98.8 %id)
AA342546 Spleen .d 5476 to 5662 187 to 1       187/187
(100 %)
0 diff
(100 %id)
AW276605 lung, two pooled squamous cell carcinomas .d 5478 to 5889 416 to 6       411/416
(98 %)
0 diff
(100 %id)
AW294371   .d 5520 to 5898 20 to 397     Submitted on the opposite strand 378/397
(95 %)
9 diff
(97.8 %id)
BF110852 carcinoid, lung .d 5530 to 6060 1 to 531   tiling clone, Submitted on the opposite strand 531/531
(100 %)
0 diff
(100 %id)
BE622458 melanotic melanoma, skin .d 5546 to 6274 1 to 725       725/935
(77 %)
59 diff
(93.7 %id)
EB387942 eye, optic nerve .d 5558 to 6380 1 to 822       822/822
(100 %)
1 diff
(99.9 %id)
AA026531 uterus .d 5572 to 6014 1 to 451       451/451
(100 %)
12 diff
(97.4 %id)
AA047394 uterus .d 5572 to 5815 1 to 244       244/248
(98 %)
1 diff
(99.6 %id)
BM723161 eye, fetal eye .d 5574 to 6036 1 to 462     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 462/462
(100 %)
1 diff
(99.8 %id)
BE613914 leiomyosarcoma, uterus .d 5590 to 6228 1 to 645       645/790
(81 %)
60 diff
(92.5 %id)
L44539   .d 5619 to 6013 396 to 1       396/396
(100 %)
13 diff
(96.8 %id)
CB053396 leiomyosarcoma, soft tissue .d 5633 to 5679 51 to 5       47/51
(92 %)
0 diff
(100 %id)
CF144481 CNCAP(3)T-225 cell line, Prostate .d 5665 to 6077 1 to 413       413/413
(100 %)
9 diff
(97.9 %id)
CF144513 CNCAP(3)T-225 cell line, Prostate .d 5665 to 6060 1 to 396       396/396
(100 %)
3 diff
(99.3 %id)
DA258129 caudate nucleus .d 5672 to 6242 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
TI_154176568   .d 5672 to 6208 80 to 616       537/543
(98 %)
12 diff
(97.8 %id)
TI_154176586   .d 5672 to 6208 80 to 616       537/542
(99 %)
11 diff
(98.0 %id)
BM719183 eye, fetal eye .d 5672 to 6380 1 to 709     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 709/709
(100 %)
1 diff
(99.9 %id)
BM838147 Ascites, stomach .d 5711 to 6367 1 to 657       657/657
(100 %)
2 diff
(99.7 %id)
BE904833 epithelioid carcinoma, Pancreas .d 5720 to 6344 1 to 622       622/910
(68 %)
8 diff
(99.2 %id)
BF981209 duodenal adenocarcinoma, cell line, small intestine .d 5745 to 6465 1 to 706       706/867
(81 %)
20 diff
(97.7 %id)
BF695810 brain, primitive neuroectoderm .d 5764 to 6486 1 to 713       713/881
(80 %)
33 diff
(96.3 %id)
CN373528 embryonic stem cells, DMSO-treated H9 cellline .d 5778 to 6060 1 to 283       283/283
(100 %)
4 diff
(98.6 %id)
FN063301 breast carcinoma .d 5789 to 5882 94 to 1     Submitted on the opposite strand 94/95
(98 %)
0 diff
(100 %id)
AV750430 Pituitary .d 5810 to 6157 1 to 339       339/340
(99 %)
6 diff
(98.3 %id)
BM677681 eye, fetal eye .d 6513 to 7177 676 to 13   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 664/664
(100 %)
1 diff
(99.9 %id)
DB360149 whole embryo, mainly body .d 6602 to 7177 572 to 1       572/575
(99 %)
10 diff
(98.3 %id)
BM683138 eye, fetal eye .d 6619 to 7180 580 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 562/562
(100 %)
0 diff
(100 %id)
DB364318   .d 6716 to 7180 468 to 1       468/468
(100 %)
10 diff
(97.9 %id)
AA047460 uterus .d 6734 to 7178 450 to 6       445/450
(98 %)
0 diff
(100 %id)
BM150311 leukopheresis .e -11 to 637 1 to 649   tiling clone,   649/649
(100 %)
4 diff
(99.4 %id)
DA283873 corpus callosum .e 1 to 570 8 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
BM827328 stomach .e 24 to 568 1 to 545       545/545
(100 %)
0 diff
(100 %id)
DA830143 placenta .e 27 to 750 2 to 733   capped   732/738
(99 %)
13 diff
(98.3 %id)
DA965359 stomach .e 27 to 586 2 to 561   capped   560/562
(99 %)
2 diff
(99.7 %id)
BP355039   .e 27 to 609 1 to 583   tiling clone,   583/583
(100 %)
2 diff
(99.7 %id)
BP204096 coronary artery .e 52 to 630 1 to 579       579/579
(100 %)
6 diff
(99.0 %id)
DA856767 placenta .e 53 to 608 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
BP278531   .e 55 to 637 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP283983 bone marrow .e 55 to 635 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA850719 placenta .e 59 to 594 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
BP223027   .e 87 to 678 1 to 592       592/592
(100 %)
3 diff
(99.5 %id)
AA126896 uterus .e 227 to 584 1 to 359     Submitted on the opposite strand 359/447
(80 %)
8 diff
(98.3 %id)
AI288597 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 228 to 706 1 to 479     Submitted on the opposite strand 479/479
(100 %)
0 diff
(100 %id)
AI367612 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 228 to 696 1 to 469     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
BF056031 pooled germ cell tumors .e 228 to 715 1 to 488     Submitted on the opposite strand 488/488
(100 %)
0 diff
(100 %id)
BF058182 fibrotheoma, ovary .e 228 to 631 1 to 404     Submitted on the opposite strand 404/404
(100 %)
0 diff
(100 %id)
AW292891   .e 229 to 890 1 to 660   tiling clone, Submitted on the opposite strand 660/660
(100 %)
4 diff
(99.4 %id)
AW298459   .e 229 to 663 1 to 435     Submitted on the opposite strand 435/435
(100 %)
0 diff
(100 %id)
AW008504 thymus, pooled .e 247 to 649 1 to 405     Submitted on the opposite strand 405/406
(99 %)
11 diff
(97.3 %id)
AI804475 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 269 to 716 1 to 448     Submitted on the opposite strand 448/452
(99 %)
1 diff
(99.8 %id)
AI401271 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 269 to 729 1 to 461     Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
DB375180 placenta .e 2489 to 2886 397 to 1   tiling clone,   397/568
(69 %)
10 diff
(98.3 %id)
DA784274 brain .f 1 to 580 2 to 581   tiling clone, capped   580/580
(100 %)
2 diff
(99.7 %id)
AK092160   .f 154 to 2677 1 to 2525 N159K G160W Q161S W162V V163G ... tiling clone, available from FLJ,   2525/2525
(100 %)
2 diff
(100.0 %id)
AX747385   .f 154 to 2677 1 to 2525 N159K G160W Q161S W162V V163G ...     2525/2525
(100 %)
2 diff
(100.0 %id)
DA691215   .f 155 to 733 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA501399 brain .f 466 to 982 2 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
DA531222 brain .f 483 to 1089 2 to 607   capped   606/606
(100 %)
3 diff
(99.6 %id)
DB323139   .f 2138 to 2677 540 to 1       540/540
(100 %)
0 diff
(100 %id)
AW977407   .g 1 to 577 9 to 586 exact tiling clone,   586/587
(99 %)
7 diff
(98.9 %id)
BM153763 leukopheresis .g 29 to 634 1 to 606   tiling clone,   606/606
(100 %)
3 diff
(99.6 %id)
DA468741   .h 1 to 557 2 to 560 T31N G32W Y33I S34Q A35C ... tiling clone, capped   559/560
(99 %)
3 diff
(99.5 %id)
AA648539 germinal center B cell .i 1 to 479 9 to 485 R23G R24A R25A D27P L28R ... tiling clone, Submitted on the opposite strand 485/487
(99 %)
9 diff
(98.2 %id)
CK002531 brain/CNS, Bulk tissue from Human Spinal cord .j 1 to 687 1 to 683 Q65X N76M E77K E78S W79G ... tiling clone,   683/685
(99 %)
7 diff
(99.0 %id)
CD693040 normal nasopharynx .k 1 to 659 22 to 680 exact tiling clone,   659/680
(96 %)
6 diff
(99.2 %id)
BP351931   .l 1 to 588 1 to 588 K25X tiling clone,   588/588
(100 %)
2 diff
(99.7 %id)
DB147239 thymus .m 1 to 566 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
DA493680 brain .m 27 to 586 2 to 563 G3V G24W S32I Q33S L34A ... tiling clone, capped   562/562
(100 %)
4 diff
(99.3 %id)
DB140724 thymus .m 27 to 561 2 to 536   tiling clone, capped   535/535
(100 %)
1 diff
(99.9 %id)
BQ685715 ductal carcinoma, cell line, Pancreas .n 1 to 733 1 to 735 S63L E64R D66G S67K S68F ... tiling clone,   735/941
(78 %)
7 diff
(99.3 %id)
AW978375   .o 1 to 587 7 to 593 exact tiling clone, AAA   587/593
(98 %)
6 diff
(99.0 %id)
N22896 melanocyte .o 2 to 587 1 to 586 A4X P6X F7L V8S Q9R ... AAA Submitted on the opposite strand 586/586
(100 %)
14 diff
(97.7 %id)
BE674982 B-cell, chronic lymphotic leukemia .o 11 to 589 1 to 579     Submitted on the opposite strand 579/579
(100 %)
0 diff
(100 %id)
DA033373   .p 1 to 552 10 to 561 S63L tiling clone, capped   560/560
(100 %)
1 diff
(99.9 %id)
AA279655 germinal center B cell .q 1 to 466 1 to 468 P7I S8A G43R G44R T45N ... tiling clone, Submitted on the opposite strand 468/468
(100 %)
5 diff
(99.0 %id)
AW573019 pooled .q 20 to 531 1 to 512   tiling clone, Submitted on the opposite strand 512/512
(100 %)
0 diff
(100 %id)
BM149803 leukopheresis .r -11 to 518 1 to 529 R22D R23A A24L P25L G26A ... tiling clone,   529/568
(93 %)
9 diff
(98.5 %id)
AA948478 pooled .r 252 to 524 1 to 274   tiling clone, Submitted on the opposite strand 274/274
(100 %)
7 diff
(97.5 %id)
AV720605 corresponding non cancerous liver tissue .s 1 to 508 509 to 2 exact tiling clone, Submitted on the opposite strand 508/509
(99 %)
2 diff
(99.7 %id)
AV718501 corresponding non cancerous liver tissue .s 2 to 509 508 to 1 exact   Submitted on the opposite strand 508/508
(100 %)
1 diff
(99.9 %id)
AV720592 corresponding non cancerous liver tissue .s 2 to 510 509 to 1 exact   Submitted on the opposite strand 509/509
(100 %)
1 diff
(99.9 %id)
AV720593 corresponding non cancerous liver tissue .s 6 to 517 512 to 1 exact tiling clone, Submitted on the opposite strand 512/512
(100 %)
2 diff
(99.7 %id)
AV720591 corresponding non cancerous liver tissue .s 8 to 519 512 to 1 exact tiling clone, Submitted on the opposite strand 512/512
(100 %)
2 diff
(99.7 %id)
AV720294 corresponding non cancerous liver tissue .s 42 to 499 458 to 1 exact   Submitted on the opposite strand 458/458
(100 %)
0 diff
(100 %id)
AV719985 corresponding non cancerous liver tissue .s 47 to 503 457 to 1 exact   Submitted on the opposite strand 457/457
(100 %)
0 diff
(100 %id)
AI023532   .t 1 to 363 1 to 362 exact tiling clone, Submitted on the opposite strand 362/362
(100 %)
5 diff
(98.7 %id)
BM153477 leukopheresis .u 1 to 300 298 to 1 N3T F7L tiling clone,   298/338
(88 %)
14 diff
(95.9 %id)
AI873406 pooled .va 1 to 269 1 to 269 P2G T4S tiling clone, Submitted on the opposite strand 269/269
(100 %)
3 diff
(98.9 %id)
AK055835 Kidney Gene OSBPL8, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
TI_927045144   Gene OSBPL8, variant not shown         Submitted on the opposite strand    
TI_927047775   Gene OSBPL8, variant not shown         Submitted on the opposite strand    
BE009464 breast_normal Gene OSBPL8, variant not shown         Submitted on the opposite strand    
BE009473 breast_normal Gene OSBPL8, variant not shown         Submitted on the opposite strand    
BE815623 breast_normal Gene OSBPL8, variant not shown              
BF957990 nervous_normal Gene OSBPL8, variant not shown              
DA233821 brain Gene OSBPL8, variant not shown       capped Suspected internal deletion, this clone was ignored    
BX953993   Gene OSBPL8, variant not shown              
AA282540 germinal center B cell Gene OSBPL8, variant not shown              
AA282667 germinal center B cell Gene OSBPL8, variant not shown              
AA282489 germinal center B cell Gene OSBPL8, variant not shown              
AA282574 germinal center B cell Gene OSBPL8, variant not shown              
AI521728 Kidney Gene OSBPL8, variant not shown         Submitted on the opposite strand    
BF243170 bone marrow, from acute myelogenous leukemia Gene OSBPL8, variant not shown         This clone was ignored    
BQ685901 ductal carcinoma, cell line, Pancreas Gene OSBPL8, variant not shown         This clone was ignored    
DB116368 thymus Gene OSBPL8, variant not shown       capped This clone was ignored    
DB343680 thymus Gene OSBPL8, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C